REFERENCES
1 – Civil Protection Department of the Italian Government:http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1(Accessed the 18th June 2020)
2 - Pennington E. Asthma increases risk of severity of COVID-19. Cleve Clin J Med. 2020. doi: 10.3949/ccjm.87a.ccc002.
3 - Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010 Sep 4;376(9743):826-34
4 - Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436-438.
5 - Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP, Brightling C, Chanez P, Dahlen SE, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014 Feb;43(2):343-73.
6 - Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, Senna G, Canonica GW; SANI Network. The Severe Asthma Network in Italy: Findings and Perspectives. J Allergy Clin Immunol Pract. 2019;7(5):1462-1468.
7 - Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, Visness CM, Durham SR, Larson D, Esnault S, Ober C, Gergen PJ, Becker P, Togias A, Gern JE, Altman MC. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020. doi: 10.1016/j.jaci.2020.04.009.
8 - Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, Woodruff PG, Mauger DT, Erzurum SC, Johansson MW, Denlinger LC, Jarjour NN, Castro M, Hastie AT, Moore W, Ortega VE, Bleecker ER, Wenzel SE, Israel E, Levy BD, Seibold MA, Fahy JV; National Heart, Lung, and Blood Institute Severe Asthma Research Program-3 Investigators. COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids. Am J Respir Crit Care Med. 2020. doi: 10.1164/rccm.202003-0821OC.
9 - Jesenak M, Banovcin P, Diamant Z. COVID‐19, chronic inflammatory respiratory diseases and eosinophils – Observationsfrom reported clinical case series. Allergy 2020. doi:10.1111/all.14353
Enrico Heffler 1,2; Aikaterini Detoraki3; Marco Contoli 4; Alberto Papi4; Giovanni Paoletti 1,2; Giacomo Malipiero 1; Luisa Brussino 5; Claudia Crimi 6; Daniela Morrone 7; Marianna Padovani 4; Giuseppe Guida8; Alberto Giovanni Gerli 9; Stefano Centanni 10; Gianenrico Senna 11; Pierluigi Paggiaro 12; Francesco Blasi13,14; Giorgio Walter Canonica 1,2on behalf of SANI Working Group *
1 Personalized Medicine, Asthma and Allergy - Humanitas Clinical and Research Center IRCCS - Rozzano (MI), Italy
2 Department of Biomedical Sciences – Humanitas University – Pieve Emanuele (MI), Italy
3 Department of Internal Medicine, Clinical Immunology, Clinical Pathology and Infectious Disease, Azienda Ospedaliera Universitaria Federico II, Napoli, Italy.
4 Department of Morphology, Surgery and Experimental Medicine - University of Ferrara – Ferrara, Italy.
5 Department of Medical Sciences, AO Ordine Mauriziano Umberto I – University of Torino - Torino, Italy.
6 Department of Clinical and Experimental Medicine - University of Catania - Catania, Italy.
7 Severe Asthma Network in Italy (SANI) infrastructure – Milano, Italy
8 Allergy and Pneumology Unit - A.O. S. Croce e Carle – Cuneo, Italy.
9 Management Engineering Tourbillon Tech srl - Padova, Italy.
10 Respiratory Unit, ASST Santi Paolo e Carlo, San Paolo Hospital, Department of Health Sciences – University of Milano - Milano, Italy.
11 Asthma Center and Allergy Unit - Verona University Hospital - Verona, Italy.
12 Department of Surgery, Medicine, Molecular Biology and Critical Care - University of Pisa - Pisa, Italy.
13 Internal Medicine Department – Respiratory Unit and Adult Cystic Fibrosis Center – Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico - Milano, Italy.
14 Department of Pathophysiology and Transplantation – University of Milano – Milano, Italy
* SANI Working Group: Bonavia M., Bucca C., Caiaffa MF., Calabrese C., Camiciottoli G., Caruso C., Conte ME., Corsico AG., Cosmi L., Costantino MT., Crimi N., D’Alò S., D’Amato M., Del Giacco S., Farsi A., Favero E., Foschino BMP., Guarnieri G., Lo Cicero S., Lombardi C., Macchia L., Mazza F., Menzella F., Milanese M., Montuschi P., Montagni M., Nucera E., Parente R., Passalacqua G., Patella V., Pelaia G., Pini L., Puggioni F., Ricciardi L., Ricciardolo FLM., Richeldi L., Ridolo E., Rolla G., Santus P., Scichilone N., Solidoro P., Spadaro G., Vianello A., Viviano V., Yacoub MR., Zappa MC.
Corresponding Author:
Prof. Enrico Heffler
Personalized Medicine, Asthma and Allergy
Istituto Clinico Humanitas
Via Alessandro Manzoni 56
20089 – Rozzano (MI) – Italy
Tel: +39 0282247013
Fax: + 39 0282246484
Email:enrico.heffler@hunimed.eu
Conflict of interest statements:
Funding statement: SANI is supported through unrestricted grants by AstraZeneca, Glaxo Smith Kline, Novartis & Sanofi Genzyme
Aknowledgements :
We are grateful to Silvia Rabotti, Concetta Sirena & the SANI staff for the invaluable work in managing the network.